Thanks, Ed. There were a lot of moving parts this quarter that impacted our financials. Consolidated revenue was $364 million for the second quarter, down 11% year-over-year. Our profitability this quarter was impacted by the $107 million aggregate loss on impairments we recognized during the quarter related to write-downs of goodwill and intangible assets related to the Fortress fire-retardant business and a goodwill impairment in the Plant Nutrition segment. As further background on the write-downs, given the sustained decrease in the company's share price and market capitalization continuing into fiscal '24 and recent developments related to its mag chloride base fire-retardants business impacting Fortress. We determined that there were indicators of impairment and therefore performed long-lived assets and goodwill impairment testing across our portfolio of assets. The analysis for Plant Nutrition resulted in no long-lived asset impairment, but did result in a goodwill impairment, while the Fortress analysis resulted in an impairment of our magnesium chloride related assets and goodwill. For the quarter, the company recognized $107 million in impairments, which were partially offset by a recognition of $21 million of other operating income, primarily related to the decline in the valuation of the contingent consideration liability associated with the Fortress acquisition. The change in that liability reflects substantial changes to our assumptions regarding the future value of the associated milestone and earnout payments given the obstacles that gave rise to the U.S. Forest Service deciding not to award us a contract for mag chloride-based fire-retardants for the upcoming fire season. Ed touched on those items briefly, and I'll elaborate on them a little more in a moment. The consolidated operating loss for the quarter was $46 million versus operating income of $48 million last year. We reported a net loss of $48 million for the quarter, which compares to a net loss of $22 million last year. Adjusted EBITDA was approximately $87 million, up 13% year-over-year. In the Salt segment, revenue totaled $310 million for the quarter, down 14% year-over-year. The mild weather that we experienced in the first quarter unfortunately continued through the second quarter, and we ultimately experienced one of the mildest winters that we have seen in our served markets over the last 25 years. Highway deicing volumes were down 22% year-over-year, and C&I volumes, which includes retail deicing products, were down 14% over the same period. Total segment volumes were down 21% year-over-year. As Ed mentioned, the Salt business is operating well from a production standpoint. However, we unfortunately simply didn't have much weather this winter to pull sales through the income statement. As one would expect with these kinds of volume declines, we saw segment operating earnings and adjusted EBITDA decline by 9% and 7% respectively in absolute dollars. However, the profitability of the business improved year-over-year with adjusted EBITDA margin increasing by approximately 200 basis points and adjusted EBITDA per ton increasing by 19% to just shy of $24. Moving on to our Plant Nutrition segment. Investors and analysts will remember that calendar '23 saw very abnormal weather conditions that impacted sales throughout last year. Demand has continued to be in a more normalized range, with volumes up 23% from the prior year. The pricing dynamic for SOP continues to track with global trade for potassium-based fertilizers, which led to a 15% decrease in price per ton year-over-year to $680 per ton. However, as Ed pointed out, sales price per ton actually increased this quarter on a sequential basis after 5 consecutive quarters of price declines. The net effect of higher volumes and lower sales pricing was an increase in Plant Nutrition revenue of 5% year-over-year. A significant portion of the Plant Nutrition business's distribution costs are fixed, so the increase in sales volumes benefited distribution costs per ton in the quarter by 12%. As noted in the press release yesterday, we recognize an impairment of goodwill in the Plant Nutrition segment of $51 million during the quarter. In the context of impairment indicators evidenced by the sustained decline in our share price and market cap, the impairment reflects tempered long-term financial assumptions for this asset. U.S. GAAP requires that these impairment costs be reflected in operating earnings, and as a result, on a reported basis, you get an all-in product cost on a per-ton basis that isn't very meaningful. Excluding the Goodwill impairment, all-in product costs per ton were down 12% year-over-year due to higher absorption of fixed costs resulting from higher sales volumes. The net impact of these drivers is that second quarter adjusted EBITDA declined slightly year-over-year as the favorable impact of higher volumes was more than offset by significantly lower pricing and higher cash costs. As a result of the developments in the fire-retardant business and the uncertainty surrounding the future use of these mag chloride-based products, we recognize a loss on impairment in the quarter of $55.6 million related to write-downs of goodwill and intangible assets at Fortress. We also recognized a non-cash gain of $24.3 million for the quarter with another operating income line item related to the decline in the valuation of the contingent consideration liability associated with the Fortress acquisition. As a reminder, when we purchased Fortress, approximately 50% of the purchase price was contingent, with roughly half of that linked to the achievement of certain business development milestones and the other half based on volume sold and paid over a 10-year period. As our expectations of the future value of those liabilities rise, we recognize non-cash losses reflecting that change. When our expectations of the future value of those liabilities decline, as they did this quarter in a major way, we recognize non-cash gains to reflect the change in value. As of March 31, the net present value of this liability was approximately $13 million. Each quarter, there will be gains and losses as the liability is revalued to reflect changes in the discount rate used in the valuation, changes in our outlook for the business, and the passage of time. These changes are not included as adjustments in the calculation of adjusted EBITDA in accordance with accounting guidance. Overall, our adjusted EBITDA as a company would have been $24 million lower if we removed that non-cash gain. Moving on to the balance sheet, at quarter end, we had liquidity of $278 million, comprised of $40 million of cash and revolver capacity of around $238 million. During the quarter, the company amended its existing credit facility to provide covenant relief and provide for greater flexibility over time across a broad range of operating scenarios. At quarter end, the consolidated total net leverage ratio was 4.3x, well within the amended covenant of 6x. As Ed noted, the actions that we have undertaken will improve our ability to generate more cash for paying down debt. Given the seasonal nature of the majority of our sales, and the timing of when most of the SG&A initiatives we are working on will manifest in the financial statements, we expect the benefits of our cash flow enhancing actions will start making a major impact on debt in fiscal '25. Moving on to our outlook for the rest of the year, regarding our Salt segment, with the conclusion of the highway deicing season, we can now narrow the range of guidance for fiscal '24. As a reminder, we entered the year with guidance resembling a bell curve that laid out $205 million in adjusted EBITDA in the event of a mild winter, $290 million in the event of a strong winter, and somewhere between $230 million and $270 million in the event of a normal winter. Clearly, coming out of a winter that saw snow events track at only approximately 60% of normal, our current guidance for the year a range of $200 million to $210 million, reflects the weak side of the original bell curve of possible outcomes we initially shared for guidance. Specifically, while sales volumes and revenues are expected to be slightly lower than what we originally projected in a mild winter scenario, our projected adjusted EBITDA for the fiscal year is in line with our original mild winter guidance of approximately $205 million. Mild weather is not the only driver of the decline in full-year guidance for the Salt segment. We are also reducing full-year guidance to reflect our expectation that we will incur certain costs in connection with temporarily reducing production levels at Goderich. Ed mentioned that we are taking steps to lower our production at Goderich mine. The decision to curtail production at Goderich mine results in incremental costs that adversely impact adjusted EBITDA guidance for this year by approximately $14 million. These costs are split roughly evenly between the remaining quarters of the year and include accelerated recognition of certain production costs. When operating within normalized production levels, fixed production costs are inventoried and then recognized as cost of goods sold expense when inventory is sold. As a result of curtailed production levels being implemented at Goderich mine being well below the mine's long run average, U.S. GAAP requires a portion of the company's fixed production costs to be reflected as expense in the periods in which they are incurred rather than as a component of inventory. Our current guidance for this segment of between $200 million and $210 million would be roughly $215 million to $225 million absent these costs we will be incurring as a result of the actions we are taking at Goderich mine. We are confident that the focus on cash flow rather than short-term impacts on EBITDA is the right approach to driving cash flow to apply towards debt reduction and ultimately the right approach to creating shareholder value. Shifting to Plant Nutrition, we have trimmed the high end of our Plant Nutrition guidance by $5 million to $30 million. And left the lower end unchanged from prior guidance at $15 million, reflecting the passage of time and our current thinking on the most likely range of potential outcomes between now and year end. Our commercial team has managed to maintain strong product pricing relative to alternative products, staying disciplined not to chase sales volumes, which are tracking towards the lower part of the provided range. Moving on to corporate, our corporate expense includes everything not related to Salt and Plant Nutrition, so it includes our corporate overhead, the cost of our now-terminated lithium program, and the impact of Fortress. Overall, at the midpoint, our total corporate cost guidance is $10 million more favorable than our prior guidance, including approximately $21 million in year-to-date non-cash gains related to the decline in the Fortress contingent consideration liability I referred to earlier. This gain is being partially offset by a $10 million reduction in our expected earnings contribution from Fortress, which has fallen to a new range of $2 million to $3 million from $13 million previously. This decline reflects the absence of a 2024 U.S. Forest Service contract and the cost of maintaining staffing while the company evaluates various alternatives for the path of this business. Our corporate expense, excluding Fortress, is tracking in line with prior guidance. Lithium-related costs are included in this number and are unchanged from what we previously reported. With respect to plan CapEx for the year, we lowered the bottom end of the range and we now expect to invest $115 million to $130 million in 2024. The change relates to the fire-retardants business where we expect CapEx to be in a range of $5 million to $10 million. That summarizes our second quarter results and our outlook for the remainder of the year. With that, I'll turn the call over for questions. Operator?